National Institutes of Health

NIH to Feinstein: Stick out that chest (bioelectrically)

By GREGORY ZELLER // With new treatments for obesity, heart failure and a host of other conditions in sight, a Feinstein Institute researcher will zero in on specific abdominal targets in a new “precision bioelectronic medicine” study. North Shore University Hospital and Long Island Jewish Medical Center Chief of Gastroenterology Larry Miller, who also directs the Gastroenterology Laboratory at the Feinstein Institute for Medical Research, has received a $1.4 million National Institutes of Health grant…


At LineaRX, putting the horsepower behind the CAR T

By GREGORY ZELLER // Marking a big step in the war against cancer, a Stony Brook-based startup has initiated pre-clinical development of a non-viral, plasmid-free chimeric antigen receptor modified T-cell manufacturing platform. In English: A novel platform designed to develop and manufacture new pharmaceutical treatments, including treatments for different forms of cancer. The tech comes from LineaRx Inc., a wholly owned subsidiary that officially spun off from Stony Brook-based Applied DNA Sciences in September. Noting…


At NYIT, a new doctorate in the house (and first PhD)

By GREGORY ZELLER // Doctor of Philosophy, we presume? And at the New York Institute of Technology, we presume correctly, now that NYIT has introduced its first-ever PhD program, joining the ranks of higher-learning institutions offering the highest academic degree conferred by a university. President Henry Foley on Friday announced that NYIT’s first Doctor of Philosophy degree program – realized through a combined Doctor of Osteopathic Medicine (D.O.)/Doctor of Philosophy (PhD) degree in Medical and…


In blockchain, best chance to secure scientific data

By HENRY FOLEY // At a recent speech in Virginia, Attorney General Jeff Sessions proclaimed that undocumented immigrants in Arizona were more likely to go to jail than U.S. citizens. His source was a study by the Crime Prevention Research Center. But there was a problem. That study had a fatal flaw that undermined its conclusion. In fact, the majority of literature on the subject actually shows the reverse. This isn’t the only example of…


Feinstein prof snags $3.5M for bladder-cancer effort

By GREGORY ZELLER // The National Institutes of Health is backing a Long Island-based researcher’s efforts to develop a first-of-its-kind care program for post-surgical bladder cancer patients. Michael Diefenbach, a fellow of both the Society of Behavioral Medicine and the Academy of Behavioral Medicine Research and a professor at Northwell Health’s Manhasset-based Feinstein Institute for Medical Research, has earned a five-year, $3.5 million grant from the NIH’s National Cancer Institute. The funds will be used…


Veteran, rookie SBU researchers earn major honors

By GREGORY ZELLER // Two Stony Brook University researchers – one with an extended résumé of scientific accomplishments, one just warming up – received some major recognition this week. R. Sekar, a professor in the Department of Computer Science in the university’s College of Engineering and Applied Sciences, has been named a SUNY Empire Innovation Professor for his cybersecurity work, which draws on disciplines ranging from programming techniques to networking to artificial intelligence. The SUNY…


Heavy-hitting LI BioMentor Initiative makes it official

By GREGORY ZELLER // A high-octane effort to unite regional bioentrepreneurs with qualified business mentors has formally launched – though the Long Island BioMentor Initiative is already quite busy. The LIBMI officially accepted its first program applications in a “launch event” Thursday morning at the de Seversky Mansion on the New York Institute of Technology’s Old Westbury campus. But the BioMentor Initiative is already a year into a “pilot phase,” according to founding mentor Mark…


No. 284: On plutonium, gun control and the video Q&A, with a Silicon Valley vibe

Friday on my mind: Spend your bread and lose your head, dear readers – you’ve reached another glorious (if wet) weekend. Reward yourself by checking out Eater’s list of highly binge-able TV options, the perfect cure for soggy Saturdays and soaked Sundays. Jiminy Crickets: Happy birthday, “Pinocchio.” The animated Disney classic debuted this date in 1940. Exactly one year later, at Berkeley, Nobel Prize winner Glenn Seaborg produced plutonium. Other debuts: Real boys (and girls)…


No. 279: A new flu review, taking the fight to tuberculosis and why your fish might really like a cold beer

Welcome to Wednesday: And over the hump we go, dear readers, with another week of Long Island innovation and socioeconomic progress in full swing. It was 179 years ago today, on Feb. 7, 1839, when U.S. Senator Henry Clay of Kentucky – warned that a speech would offend abolitionists and pro-slavery factions alike, and could cost him the presidential election – told Congress, “I had rather be right than be president.” The nose knows: Walt…


Northwell sings the praises of $15 million CHIOR

Heralding “an incubator for innovation,” Michael Dowling and the Northwell Health system have opened the doors of the Center for Health Innovations and Outcomes Research. Dowling, president and CEO of the New Hyde Park-based health system, presided over a ceremonial ribbon-cutting event in November, officially christening the 20,000-square-foot, $15 million Manhasset facility, part of the Feinstein Institute for Medical Research. Leveraging Northwell Health’s uniquely large and diverse patient population, the CHIOR is designed specifically to…


NIH grant links LI researcher to top diabetes study

By GREGORY ZELLER // A multiyear federal grant will plug a top Long Island researcher into medical science’s foremost diabetes study. Alan Jacobson, chief research officer at Mineola-based NYU Winthrop Hospital, has secured a $4.23 million stipend from the National Institutes of Health to study the long-term neurocognitive effects of type 1 diabetes. The five-year grant will help Jacobson better understand how the disease – which affects more than 1.25 million Americans, according to the…


Codagenix scores again: $3M to hunt down deadly RSV

By GREGORY ZELLER // A fresh $3 million in public and private investments has set Codagenix Inc. on the trail of another nefarious disease. Already developing vaccines for Zika virus, the mutating menace Influenza A and a host of other viral villains, Codagenix will now focus its vaccine-creation might on Respiratory Syncytial Virus through a $1.5 million Phase II Small Business Innovation Research grant from the National Institutes of Health and another $1.5 million in…


NIH sees a need for speed in Traverse Biosciences

By GREGORY ZELLER // The National Institutes of Health has welcomed a rising Stony Brook biotech into its competitive Commercialization Accelerator Program. Traverse Biosciences, which is attempting to commercialize novel drug candidates for the treatment of inflammatory diseases affecting animals and humans, has landed one of 80 annual slots in the CAP, a nine-month program hosted by the NIH and the Larta Institute, a California-based networking group promoting international innovation. The NIH CAP – which…


Feds back NYIT professors on RNA-sequencing quest

By GREGORY ZELLER // Diverse disciplines are coming together at NYIT, where a multi-year National Institutes of Health grant is fueling next-level RNA research – and, possibly, opening a new front in the war against cancer. Two New York Institute of Technology faculty members, assistant professors of life sciences and computer sciences, will combine their skills under a three-year, $568,000 Cutting Edge Basic Research award from the NIH’s National Human Genome Research Institute. Their mission:…


Feds fund NYIT ‘skeletal repair’ research

A New York Institute of Technology professor has landed a sizeable federal grant to study the bone-healing possibilities of gene-generated “skeletal repair.” The National Institutes of Health has awarded $442,000 to life sciences professor Michael Hadjiargyrou, who will use the multi-year grant to study Mustn1, a newly discovered musculoskeletal-specific gene, and “determine its role in cartilage regeneration and skeletal repair,” according to NYIT. Hadjiargyrou’s research will also shed light on a new and as yet…